Litcius/Paper detail

The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study

Aris Bechlioulis, Georgios Markozannes, Ifigeneia Chionidi, Evangelos Liberopoulos, Katerina Κ. Naka, Evangelia Ntzani, Stavros Liatis, Manfredi Rizzo, Evangelos C. Rizos

2023Journal of Diabetes and its Complications29 citationsDOI

Topics & Concepts

EmpagliflozinLiraglutideMedicineArterial stiffnessPulse wave velocityType 2 diabetesInternal medicinePopulationCardiologyBlood pressureRandomized controlled trialDiabetes mellitusEndocrinologyEnvironmental healthCardiovascular Health and Disease PreventionDiabetes Treatment and ManagementCardiovascular Function and Risk Factors
The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study | Litcius